Small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up von Dingemans, A.-M.C., Früh, M., Ardizzoni, A., Besse, B., Faivre-Finn, C., Hendriks, L.E., Lantuejoul, S., Peters, S., Reguart, N., Rudin, C.M., De Ruysscher, D., Van Schil, P.E., Vansteenkiste, J., Reck, M.

Volltext

Nivolumab-induced cholangitic liver disease: a novel form of serious liver injury von Gelsomino, F., Vitale, G., D’Errico, A., Bertuzzi, C., Andreone, P., Ardizzoni, A.

Volltext

Grading the neuroendocrine tumors of the lung: an evidence-based proposal von Rindi, G, Klersy, C, Inzani, F, Fellegara, G, Ampollini, L, Ardizzoni, A, Campanini, N, Carbognani, P, De Pas, T M, Galetta, D, Granone, P L, Righi, L, Rusca, M, Spaggiari, L, Tiseo, M, Viale, G, Volante, M, Papotti, M, Pelosi, G

Volltext

Diabetes mellitus induced by immune checkpoint inhibitors: type 1 diabetes variant or new clinical entity? Review of the literature von Lo Preiato, V., Salvagni, S., Ricci, C., Ardizzoni, A., Pagotto, U., Pelusi, C.

Volltext

Cisplatin- Versus Carboplatin-Based Chemotherapy in First-Line Treatment of Advanced Non–Small-Cell Lung Cancer: An Individual Patient Data Meta-analysis von Ardizzoni, Andrea, Boni, Luca, Tiseo, Marcello, Fossella, Frank V., Schiller, Joan H., Paesmans, Marianne, Radosavljevic, Davorin, Paccagnella, Adriano, Zatloukal, Petr, Mazzanti, Paola, Bisset, Donald, Rosell, Rafael

Volltext

Comparison of HER2 status in primary and paired metastatic sites of gastric carcinoma von Bozzetti, C, Negri, F V, Lagrasta, C A, Crafa, P, Bassano, C, Tamagnini, I, Gardini, G, Nizzoli, R, Leonardi, F, Gasparro, D, Camisa, R, Capelli, S, Silini, E M, Ardizzoni, A

Volltext

Programmed death-1 inhibition and atherosclerosis: can nivolumab vanish complicated atheromatous plaques? von Gelsomino, F., Fiorentino, M., Zompatori, M., Poerio, A., Melotti, B., Sperandi, F., Gargiulo, M., Borghi, C., Ardizzoni, A.

Volltext

EGFR and EML4-ALK gene mutations in NSCLC: A case report of erlotinib-resistant patient with both concomitant mutations von Tiseo, M, Gelsomino, F, Boggiani, D, Bortesi, B, Bartolotti, M, Bozzetti, C, Sammarelli, G, Thai, E, Ardizzoni, A

Volltext

ERCC1/BRCA1 expression and gene polymorphisms as prognostic and predictive factors in advanced NSCLC treated with or without cisplatin von Tiseo, M, Bordi, P, Bortesi, B, Boni, L, Boni, C, Baldini, E, Grossi, F, Recchia, F, Zanelli, F, Fontanini, G, Naldi, N, Campanini, N, Azzoni, C, Bordi, C, Ardizzoni, A

Volltext

Lung adenocarcinomas with mucinous histology: clinical, genomic, and immune microenvironment characterization and outcomes to immunotherapy-based treatments and KRASG12C inhibitors von Di Federico, A., Hong, L., Elkrief, A., Thummalapalli, R., Cooper, A.J., Ricciuti, B., Digumarthy, S., Alessi, J.V., Gogia, P., Pecci, F., Makarem, M., Gandhi, M.M., Garbo, E., Saini, A., De Giglio, A., Favorito, V., Scalera, S., Cipriani, L., Marinelli, D., Haradon, D., Nguyen, T., Haradon, J., Voligny, E., Vaz, V., Gelsomino, F., Sperandi, F., Melotti, B., Ladanyi, M., Zhang, J., Gibbons, D.L., Heymach, J.V., Nishino, M., Lindsay, J., Rodig, S.J., Pfaff, K., Sholl, L.M., Wang, X., Johnson, B.E., Jänne, P.A., Rekhtman, N., Maugeri-Saccà, M., Heist, R.S., Ardizzoni, A., Awad, M.M., Arbour, K.C., Schoenfeld, A.J., Vokes, N.I., Luo, J.

Volltext

Randomized phase II trial of gemcitabine–cisplatin with or without trastuzumab in HER2-positive non-small-cell lung cancer von Gatzemeier, U., Groth, G., Butts, C., Van Zandwijk, N., Shepherd, F., Ardizzoni, A., Barton, C., Ghahramani, P., Hirsh, V.

Volltext

Clinical significance of ROS1 5’ deletions detected by FISH and response to crizotinib von Dall’Olio, F.G., Lamberti, G., Capizzi, E., Gruppioni, E., Sperandi, F., Altimari, A., Giunchi, F., Fiorentino, M., Ardizzoni, A.

Volltext

An open-label, randomized phase III study of early switch maintenance vs delayed second-line nivolumab in advanced stage squamous non-small cell lung cancer (NSCLC) patients after... von Gelsomino, F., Tiseo, M., Boni, L., Cavanna, L., Camerini, A., Chiari, R., Verusio, C., Tognetto, M., Ardizzoni, A.

Volltext

KRAS and ERBB-family genetic alterations affect response to PD-1 inhibitors in metastatic non-squamous NSCLC von Cinausero, M., Laprovitera, N., De Maglio, G., Gerratana, L., Riefolo, M., Macerelli, M., Fiorentino, M., Porcellini, E., Buoro, V., Gelsomino, F., Squadrilli, A., Fasola, G., Tiseo, M., Ferracin, M., Ardizzoni, A.

Volltext

Dihydropyrimidine dehydrogenase (DPD) deficiency: how to translate it in clinical practice? von Adua, D., Del Re, M., Rojas Limpe, F.L., Casolari, L., Danesi, R., Di Fabio, F., Ardizzoni, A.

Volltext

Dose-determination results from a phase Ib/II study of ceritinib (CER) + ribociclib (RIB) in ALK-positive (ALK+) non-small cell lung cancer (NSCLC) von Santoro, A., Su, W.-C., Navarro, A., Simonelli, M., Yang, J.C.-H., Ardizzoni, A., Barlesi, F., Kang, J.H., Didominick, S., Abdelhady, A., Goswami, B., Crystal, A., Felip, E.

Volltext

Liver metastases from prostate cancer at 11C-Choline PET/CT: a multicenter, retrospective analysis von Ghedini, Pietro, Bossert, I., Zanoni, L., Ceci, F., Graziani, T., Castellucci, P., Ambrosini, V., Massari, F., Nobili, E., Melotti, B., Musto, A., Zoboli, S., Antunovic, L., Kirienko, M., Chiti, A., Mosconi, C., Ardizzoni, A., Golfieri, R., Fanti, S., Nanni, C.

Volltext

Phase II study of NAB-paclitaxel in sensitive and refractory relapsed SCLC (NABSTER TRIAL) von Gelsomino, F., Tiseo, M., Barbieri, F., Riccardi, F., Cavanna, L., Frassoldati, A., Delmonte, A., Longo, L., Dazzi, C., Cinieri, S., Colantonio, I., Tognetto, M., Baldari, D., Tofani, L., Ardizzoni, A.

Volltext

Immune-checkpoint inhibitors in previously treated patients with urothelial carcinoma: A systematic review and meta-analysis von De Luca, E., Di Nunno, V., Buttigliero, C., Tucci, M., Vignani, F., Zichi, C., Ardizzoni, A., Massari, F., Di Maio, M.

Volltext

Correlation of cytidine deaminase polymorphisms and activity with clinical outcome in gemcitabine-/platinum-treated advanced non-small-cell lung cancer patients von Tibaldi, C., Giovannetti, E., Tiseo, M., Leon, L.G., D'Incecco, A., Loosekoot, N., Bartolotti, M., Honeywell, R., Cappuzzo, F., Ardizzoni, A., Peters, G.J.

Volltext